Vitamin B12 and D Deficiency as Cofactors of COVID-19 Vaccine-Induced Chronic Neurological Adverse Reactions: Two Cases and a Hypothesis

Why It Matters

Identifying micronutrient deficiencies before immunization may prevent prolonged, debilitating vaccine‑related neurologic sequelae, informing both clinical practice and public‑health policy.

Key Takeaways

• Vitamin B12 deficiency observed in both vaccine adverse cases.
• Case 1 recovered fully after B12 supplementation, even post‑boost.
• Case 2 exhibited long COVID‑like syndrome with microclots.
• Elevated homocysteine persisted despite B12, required folic acid.
• Authors recommend pre‑vaccination B12 screening for high‑risk groups.

Pulse Analysis

The emergence of rare but serious neurological complications after COVID‑19 vaccination has prompted clinicians to look beyond the immune response and examine patients' baseline health status. Micronutrients such as vitamin B12 and D play critical roles in nerve myelination, mitochondrial function, and coagulation pathways. When these nutrients are deficient, the body’s ability to manage inflammatory and thrombotic stressors may be compromised, creating a fertile ground for prolonged adverse events that mimic long‑COVID symptoms. Understanding this interplay helps clinicians differentiate vaccine‑related pathology from other etiologies and supports a more nuanced risk‑benefit assessment.

In the two cases described, the first patient’s symptoms resolved promptly with B12 repletion, underscoring the reversible nature of deficiency‑driven neurotoxicity. The second patient, however, presented a complex picture: persistent dyspnea, microclot formation, mast‑cell activation, and dysautonomia, all despite aggressive B12 and vitamin D supplementation. Elevated homocysteine levels suggested incomplete methylation cycles, necessitating folic acid addition. This constellation mirrors emerging data on post‑acute sequelae of SARS‑CoV‑2 infection, indicating that vaccine‑induced immune activation can trigger similar downstream cascades when metabolic reserves are low.

These observations have immediate implications for clinical practice. Routine screening for B12 (and possibly vitamin D) in individuals following strict vegan diets, those with prior unexplained neurologic complaints, or patients slated for booster doses could identify hidden vulnerabilities. Early correction may avert chronic symptomatology, reduce healthcare utilization, and maintain public confidence in vaccination programs. Moreover, the cases highlight the need for multidisciplinary evaluation—hematology, neurology, and immunology—to fully map the pathophysiology of vaccine‑associated long‑COVID‑like syndromes, paving the way for targeted therapeutic strategies.